Cystamine Inhibits Caspase Activity
Open Access
- 1 February 2003
- journal article
- Published by Elsevier BV
- Vol. 278 (6), 3825-3830
- https://doi.org/10.1074/jbc.m205812200
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Pathogenesis of Inclusion Bodies in (CAG)n/Qn-Expansion Diseases with Special Reference to the Role of Tissue Transglutaminase and to Selective VulnerabilityJournal of Neurochemistry, 2008
- Proteasome inhibitors induce caspase‐dependent apoptosis and accumulationof p21WAF1/Cip1 in human immatureleukemic cellsEuropean Journal of Haematology, 2000
- Tissue Transglutaminase Is Increased in Huntington's Disease BrainJournal of Neurochemistry, 1999
- Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretchNature Genetics, 1998
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- Mitochondria, free radicals, and neurodegenerationCurrent Opinion in Neurobiology, 1996
- Transglutaminase factor XIII uses proteinase‐like catalytic triad to crosslink macromoleculesProtein Science, 1994
- Huntington's disease, energy, and excitotoxicityNeurobiology of Aging, 1994
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993
- Modulation of glutathione content and the effect on methionine auxotrophy and cellular distribution of homocysteine and cysteine in mouse cell linesCarcinogenesis: Integrative Cancer Research, 1991